Turning Point Therapeutics, Inc. - Common stock (TPTX): Price and Financial Metrics
TPTX Price/Volume Stats
| Current price | $76.01 | 52-week high | $82.20 |
| Prev. close | $75.49 | 52-week low | $23.77 |
| Day low | $75.98 | Volume | 2,843,300 |
| Day high | $76.01 | Avg. volume | 1,137,726 |
| 50-day MA | $74.99 | Dividend yield | N/A |
| 200-day MA | $45.62 | Market Cap | 3.81B |
TPTX Stock Price Chart Interactive Chart >
Turning Point Therapeutics, Inc. - Common stock (TPTX) Company Bio
Turning Point Therapeutics, Inc. engages in the discovery and development of precision medicines for cancer and other diseases. It focuses on the design of novel chemical identities for established oncogene drivers with secondary resistant mutations, newly identified disease-driven targets, and potential targets regulating tumor microenvironment and tumor immunity. The company was founded by J. Jean Cui and Y. Peter Li in October 2013 and is headquartered in San Diego, CA.
Latest TPTX News From Around the Web
Below are the latest news stories about Turning Point Therapeutics Inc that investors may wish to consider to help them evaluate TPTX as an investment opportunity.
Turning Point Therapeutics (TPTX) Investor Presentation - SlideshowThe following slide deck was published by Turning Point Therapeutics, Inc. in conjunction with this event.... |
TPTX Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | 4.08% |
| 5-year | 185.00% |
| YTD | N/A |
| 2023 | N/A |
| 2022 | 0.00% |
| 2021 | -60.85% |
| 2020 | 95.62% |
| 2019 | N/A |
Loading social stream, please wait...